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Abstract 
This paper designed to examine research published in PubMed indexed journals of different 
treatment modalities to treat COVID -19 infection employing bibliometric analysis technique from 
2020 to 2021. The purpose was to consolidate the published scholarly work in the PubMed 
database on different treatment modalities including vaccine, oxygen supplementation, 
dexamethasone or steroids, aspirin, heparin, remdesivir, zinc, vitamin c or ascorbic acid, oxygen, 
anti-malarial like chloroquine and hydroxychloroquine, and azithromycin or macrolides. We 
employed a bibliometric analysis technique and found a total of 3043 published documents. The 
study findings depicted that vaccine and COVID-19 top was at the top of the list of topics of the 
published documents along with the United States as a top productive country. The name of 
Mahase E secured the first position in top authors, Univ. Maryland as a top organization, COVID-
19 as a top keyword, COVID as top term analysis by title, and 'BMJ (Clinical Research Ed.)’ was 
the top of the published documents.  
Keywords: Vaccine, Anti-Malarial, Remedisivir, Azithromycin, Oxygen Supplementation, 
Dexamethasone, Heparin, Zinc, Ascorbic Acid, Aspirin, COVID-19, Bibliometric Analysis 
Introduction 
In this paper, we have evaluated the trend of treatment modalities to treat COVID -19 infection 
employing bibliometric analysis techniques from 2020 to 2021. This was in late 2019 when a 
cluster of atypical pneumonia cases was reported in Hubei, Wuhan, China (Shoaib & Abdullah, 
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2020, 2021). The presentation was atypical and there was a suspicion of person-to-person 
transmission of pneumonia. The causative organisms for the pneumonia were unknown. World 
Health Organization was intimated about these cases in December 2019. In February 2020, the 
cause of these atypical pneumonia cases was determined, and a novel coronavirus was found to be 
the cause of these atypical cases of pneumonia. This virus was named COVID-19 alternative name 
for this virus is SARS CoV 19. Coronaviruses are well known to causes human and animal 
diseases. These viruses are also known for their infectivity potential. It was due to this infectivity 
potential that almost all the countries of the world were involved in a matter of months and the 
outbreak was declared as a pandemic by World Health Organization in March 2020 (Shoaib & 
Abdullah, 2020, 2021). The viruses can infect animals and can also change their primary host. It 
is postulated that novel coronavirus was transmitted to human beings from bats. Similar 
transmission from animals to humans was reported previously as well as the Middle East 
Respiratory Syndrome. The causative coronavirus for MERS was transmitted to human beings 
from camels. These viruses can undergo mutations and can cause a wide range of symptoms.  
The objective of the study 
The main objective of the study was to examine research published in PubMed indexed journals 
of different treatment modalities to treat COVID -19 infection employing bibliometric analysis 
techniques from 2020 to 2021. The main treatment options that were used to formulate this study 
were a vaccine, oxygen supplementation, dexamethasone or steroids, aspirin, heparin, remdesivir, 
zinc, vitamin c or ascorbic acid, oxygen, anti-malarial like chloroquine and hydroxychloroquine, 
and azithromycin or macrolides. Further, it was dissected into the following sub-headings; 
➢ Topic in PubMed and top countries 
➢ Documents by top authors, organizations, and keywords 
➢ Term analysis by titles and top productive sources 
Review of Literature 
Several studies had been conducted to examine the signs and symptoms of COVID-19 in all over 
the world. Empirical evidences showed that it affected several countries and number of casualties 
were also reported. As COVID 19 can cause symptoms ranging from mild flu to severe and life-
threatening pneumonia. Initially, it was thought that only the respiratory tract is involved by 
COVID 19, but with rapid spread and increased cases, it was known that its effects are present not 
only on the respiratory tract but other organ systems that are also involved (White-Dzuro et al., 




2021; Whiteside et al., 2021). Its presentation included fever, headache, shortness of breath, cough, 
fatigue, anosmia, and decreased appetite (Wagner et al., 2021; Wang et al., 2021). It also had an 
atypical presentation with the presenting complaint being the formation of intravascular blood 
clots, stroke, myocardial infarction, sepsis, pneumonia, and DIC (Ranjit et al., 2021; 
Shchendrygina et al., 2021; Uzunova et al., 2021). The presentation and severity of symptoms 
depend upon the host characteristics (Bury et al., 2021; Cabañas et al., 2021). Generally, COVID 
19 causes severe and life-threatening symptoms in old and immunocompromised hosts and mild 
to no symptoms in healthy and young hosts (Abdel-Moneim & Hosni, 2021). Since the start of the 
pandemic nations around the world had focused on preventive measures to stop the spread of this 
infection (Shoaib & Abdullah, 2020, 2021). As the mode of spread of this virus is through droplets, 
so the preventive measures included the wearing of facemasks, social distancing, frequent washing 
of hands, isolation of positive cases, and lockdowns in case of emergence of a cluster of positive 
cases in any locality (Sharfuddin, 2020; Swerdlow et al., 2020; Van-der Linden et al., 2020).  
Despite all these efforts the virus was spreading exponentially and caused significant social, 
psychological, and financial damage (Romano et al., 2020; Sah et al., 2020; Seraphin, 2020; 
Shakespeare-Finch et al., 2020). Healthcare facilities around the world were overwhelmed due to 
the increased number of cases (Rismiller et al., 2020). Initially, there was no proven treatment for 
COVID 19 infection, and a search to find a cure and treat the disease was started (Parnell et al., 
2020). Moreover, research to develop a vaccine to prevent the occurrence of this disease was also 
initiated. A significant drop in oxygen saturation was observed in the patients having moderate to 
severe COVID 19 pneumonia (Lum et al., 2020). Therefore, oxygen supplementation is part of the 
treatment protocol from the start of this pandemic. Similarly, it was found that much of the damage 
due to COVID 19 is due to the inflammatory response of the body, hence anti-inflammatory 
medications were also added to the regimen. Trails and research around the world showed 
promising results and benefits if the patients were given vitamin C and zinc and these were also 
introduced in the treatment protocol, Antimicrobials like azithromycin, chloroquine, and 
remdesivir also showed to hasten recovery and improve patient's outcome (Bridwell et al., 2020; 
Freedman, 2020; Hendaus & Jomha, 2020; Hurford, 2020). There was extensive research and 
publication of these treatment modalities. This bibliometric study is focused to study the PubMed 
cited publications whose focus was studying different aspects of these treatment modalities. 
Several studies had been conducted employing bibliometric analysis techniques to evaluate the 




scholarly published work in different data bases (Shoaib et al., 2020; Ullah & Shoaib, 2021). 
However, researcher also opted other different research techniques including qualitative and 
quantitative to draw results and conclusion on different issues in different field of study (Ali et al., 
2021; Shoaib et al., 2020; Shoaib et al., 2021). Hence, the main treatment options that were used 
to formulate this study were a vaccine, oxygen supplementation, dexamethasone or steroids, 
aspirin, heparin, remdesivir, zinc, vitamin c or ascorbic acid, oxygen, anti-malarial like 
chloroquine and hydroxychloroquine, and azithromycin or macrolides. Further, several studies had 
been conducted to analyze published document in different databases employing bibliometric 
analysis techniques to show the trend of data (Ali et al., 2021; Shaukat et al., 2021; Shoaib et al., 
2021; Ullah & Shoaib, 2021). However, several researchers also used other qualitative and 
quantitative techniques to conduct their studies including survey, case studies, and field researches 
(Ali et al., 2021; Mariam et al., 2021; Shoaib & Abdullah, 2021; Shoaib et al., 2020; Shoaib et al., 
2021; Shoaib & Ullah, 2021a, 2021b). 
The Data and Methods 
This study was purely based on the bibliometric analysis and did not outline the methods as we 
did it for survey research or primary data analysis. For the scientometric analysis, the data was 
extracted from PubMed database. It was a free search engine accessing primarily the MEDLINE 
database of references and abstracts on life sciences and biomedical topics. The United States 
National Library of Medicine at the National Institutes of Health maintain the database as part of 
the Entrez system of information retrieval. The searched query was used as: 
(((((((((((Azithromycin[Title]) OR (Macrolide[Title])) AND (COVID[Title])) OR ((((Anti-
malarial[Title]) OR (Chloroquine[Title])) OR (Hydroxychloroquine[Title])) AND 
(COVID[Title]))) OR ((COVID[Title]) AND (Oxygen[Title]))) OR (((Vitamin C[Title]) OR 
(Ascorbic Acid[Title])) AND (COVID[Title]))) OR ((COVID[Title]) AND (Zinc[Title]))) OR 
((COVID[Title]) AND (Remdesivir[Title]))) OR ((COVID[Title]) AND (Heparin[Title]))) OR 
((COVID[Title]) AND (Aspirin[Title]))) OR ((COVID[Title]) AND (Vaccine[Title]))) OR 
(((Dexamethasone[Title]) OR (Steroid[Title])) AND (COVID[Title])). It is important here to 
mention that the data was extracted on May 02, 2021 at 02:13 AM, PST with timespan of 2020 to 
2021.  The retrieved keywords by topics were reported as COVID and vaccine 1280, COVID and 
dexamethasone or steroids 128, COVID and aspirin 23, COVID and heparin 99, COVID and 
remedisivir 247, COVID and zinc 61, COVID and vitamin c or ascorbic acid 44, COVID and 




oxygen 160, COVID and anti-malarial OR chloroquine OR hydroxychloroquine 835, COVID and 
azithromycin OR macrolide 166. Further, Biblioshiny, VOSviewer, and MS Excel software was 
used to draw results and conclusion.  
Results and Discussion  
This section provides the results and discussion based on the bibliometric analysis on the subject 
of the issue of COVID-19. The results are presented in terms of the objective of the study. 
Topic in PubMed and Top Countries 
Table 1 depicted the distribution of the published documents based on topic and top countries. 
Data indicated that vaccine and COVID-19 were at the top of the list of topics used in the published 
documents with a percentage of 42.06 in 2020 to 2021. Similarly, the topic ‘Anti-Malarial OR 
Chloroquine OR Hydroxychloroquine AND COVID-19' secured second position in the list of 
topics of the published documents with a percentage of 27.44. However, only 0.76 percent of the 
published documents were published with the topic of 'Aspirin AND COVID-19' from 2020 to 
2021. It is pertinent to mention here that there were a very smaller proportion of the published 
documents with the topic including Remedisivir AND COVID-19, Azithromycin OR Macrolide 
AND COVID-19, Oxygen AND COVID-19, Dexamethasone OR Steroids AND COVID-19, 
Heparin AND COVID-19, Zinc AND COVID-19, and Vitamin C OR Ascorbic Acid AND 
COVID-19. To sum up the debate, the topic ‘Vaccine AND COVID-19' secured the top position 
in the published documents on the subject.  
The results in Table 1 also depict the overall top productive countries of the published documents. 
Data described that the United States was placed at the list of top countries of the published 
documents with 437 publications, 335 single country publications, and 102 multiple country 
publications in 2020 to 2021. Similarly, the country India secured the second position in the list of 
top-name of countries of the published documents with 180 publications, 140 single country 
publications, and 40 multiple country publications. Contrary to it, the name of Japan was at the 
bottom of the list of the top countries of the published documents on the subject with 18 
publications, 16 single country publications, and 02 multiple country publications. It is worth 
mentioning to state that the name of France, Italy, China, Canada, Spain, Iran, Germany, Brazil, 
Turkey, Australia, Netherlands, Egypt, United Kingdom, Israel, Saudi Arabia, Belgium, and 
Denmark was also in the list of top countries of the published documents.  
 









2020 2021 Total 
Vaccine AND COVID-19  464 816 1280 42.06 
Anti-Malarial OR Chloroquine OR 
Hydroxychloroquine AND COVID-19 
600 235 835 27.44 
Remedisivir AND COVID-19 159 88 247 8.12 
Azithromycin OR Macrolide AND COVID-19 102 64 166 5.46 
Oxygen AND COVID-19 90 70 160 5.26 
Dexamethasone OR Steroids AND COVID-19 71 57 128 4.20 
Heparin AND COVID-19 64 35 99 3.25 
Zinc AND COVID-19 29 32 61 2.00 
Vitamin C OR Ascorbic Acid AND COVID-19 29 15 44 1.45 
Aspirin AND COVID-19 09 14 23 0.76 
Total 1617 1426 3043 100.00 
Overall Top Productive Countries 
Country TP* Freq. SCP* MCP* MCP*_Ratio 
USA 437 0.224218 335 102 0.233 
India 180 0.092355 140 40 0.222 
France 159 0.08158 122 37 0.233 
Italy 140 0.071832 118 22 0.157 
China 128 0.065675 93 35 0.273 
Canada 66 0.033864 40 26 0.394 
Spain 57 0.029246 31 26 0.456 
Iran 55 0.02822 42 13 0.236 
Germany 48 0.024628 30 18 0.375 
Brazil 47 0.024115 39 08 0.170 
Turkey 43 0.022063 38 05 0.116 
Australia 35 0.017958 19 16 0.457 
Netherlands 34 0.017445 28 06 0.176 
Egypt 33 0.016932 21 12 0.364 
United Kingdom 29 0.014879 20 09 0.310 
Israel 28 0.014366 21 07 0.250 
Saudi Arabia 28 0.014366 14 14 0.500 
Belgium 25 0.012827 16 09 0.360 
Denmark 20 0.010262 08 12 0.600 
Japan 18 0.009236 16 02 0.111 
TP* = Total Publication, SCP* = Single Country Publications, MCP* = Multiple Country 
Publications 
 




Documents by Top Authors, Organizations, and Keywords 
Table 2 
Distribution of the Documents by Top Authors, Organizations, and Keywords 
Overall Top Productive Authors 
Author f % Author f % 
Mahase E 56 1.84 Colson P 13 0.43 
Raoult D 35 1.15 Dhama K 13 0.43 
Gautret P 28 0.92 Li C 13 0.43 
Lagier JC 26 0.85 Li H 12 0.39 
Honor S 20 0.66 Li Y 12 0.39 
Million M 16 0.53 Liu Y 11 0.36 
Brouqui P 15 0.49 Wang X 11 0.36 
Hoang VT 14 0.46 Dyer O 11 0.36 
Rolain JM 14 0.46 Iacobucci G 11 0.36 
Wang Y 13 0.43 Ledford H 11 0.36 
Top Productive Organizations 
Organizations f % Organizations f % 
Univ. Maryland 82 1.885 Virginia 
Commonwealth Univ. 
54 1.241 
Univ. Toronto 75 1.724 Univ. Denver 49 1.126 
Univ. Georgia 67 1.54 Rutgers State Univ. 48 1.103 
Univ. N Carolina 63 1.448 Univ. Connecticut 47 1.08 
Univ. Michigan 62 1.425 Univ. Washington 46 1.057 
Arizona State Univ. 58 1.333 Florida State Univ. 45 1.034 
Univ. Illinois 58 1.333 Univ. Texas Austin 45 1.034 
NYU 56 1.287 Univ. Calgary 41 0.942 
Univ. Tennessee 55 1.264 Univ. Kansas 39 0.896 
Univ. Calif Berkeley 54 1.241 Fordham Univ. 38 0.873 
Occurrences of Keywords 
Keyword f Total Link 
Strength 
Keyword f Total Link 
Strength 
COVID-19 1981 18029 Male 387 5795 
Humans 1571 17255 Antiviral Agents 322 4180 
SAR-CoV-2 1354 13757 Middle Aged 319 4957 
Pandemics 873 10759 Adult 278 4119 
Coronavirus Infections 747 9491 Aged 275 4259 
Pneumonia, Viral 717 9286 Chloroquine 243 2316 
Hydroxychloroquine 647 6466 Treatment Outcome 216 3158 
Betacoronavirus 605 7943 Azithromycin 192 2309 
COVID-19 Vaccines 535 5375 Viral Vaccines 168 2181 
Female 398 5950 Vaccination 165 1670 
 
Table 2 described the top author, organizations, and keywords of the published documents on the 
subject under discussion. Data based on the bibliometric analysis depicted that the name of Mahase 
E was on the top of the list of overall top productive authors with 56 publications. Similarly, the 




name of Raoult D secured a second position with 35 publications. Further, the name Gautret P 
placed at third position in the list of top productive authors with 28 published documents. Opposite 
to it, the name of Ledford H was placed at the bottom of the top productive author's list with 11 
publications. It is important to mention here that the name of Colson P, Dhama K, Li C, Li H, Li 
Y, Liu Y, Wang X, Dyer O, Iacobucci G, Honor S, Million M, Brouqui P, Hoang VT, Rolain J M, 
and Wang Y was also in the list of top productive authors of the published documents in 2020 to 
2021.  
 
Figure 1. Occurrences of Keywords 
Data in the Table 2 described the top productive organizations of the published documents from 
2020 to 2021 on the subject under discussion. It showed that the name of Univ. Maryland wat at 
the top of the list of productive organizations with 82 published documents. Similarly, the name 
of Univ. Toronto secured the second position in the list of top organizations with 75 publications. 
However, the name of Fordham Univ. was at the bottom of the list of top productive organizations 
with 38 publications. It is important to mention here that the name of Florida State Univ. and Univ. 
Texas Austin organization published an equal number of documents i.e., 45. Similar to it, the name 




of Arizona State Univ. and Univ. Illinois was also published similar documents i.e., 58 in numbers. 
Moreover, the name of Univ. Georgia, Univ. N Carolina, Univ. Michigan, Virginia, 
Commonwealth Univ., Univ. Denver, Rutgers State Univ., Univ. Connecticut, Univ. Washington, 
NYU, Univ. Tennessee, Univ. Calif Berkeley, Univ. Calgary, and Univ. Kansas was also on the 
list of top organizations of the published documents from 2020 to 2021.  
Table 2 also presented the top occurrence of keywords in the published documents from 2020 to 
202. Analysis showed that the COVID-19 keyword was placed at the top of the list of top keywords 
of the published documents with the occurrence of 1981. Similarly, humans keywords secured the 
second position in the list of top keywords with an occurrence of 1571, and SAR-CoV-2 placed at 
third position with an occurrence of 1354 keywords. Contrary to it, the vaccination keyword was 
at the bottom of the list of the top keywords of the published documents with 165 occurrences 
from 2020 to 2021. It is worth mentioning here that the name of the keyword including male, 
antiviral agents, middle-aged, adult, aged, chloroquine, treatment outcome, azithromycin, viral 
vaccines, pandemics 
coronavirus infections, pneumonia, viral, hydroxychloroquine, betacoronavirus, COVID-19 
vaccines, and female. To conclude the discussion, the keyword vaccination was at the top of the 
list of top keywords of the published documents.  
Term Analysis by Titles and Top Productive Sources 
Data in the Table 3 illustrated the term analysis of titles and top productive sources. Bibliometric 
analysis showed that the term COVID was placed at top of the list of term analysis by title with 
the frequency of 2632 and vaccine secured the second position as a term analysis by titles of the 
published documents from 2020 to 2021 on the subject under discussion. However, the term adult 
was at the bottom of the list of top term analysis by titles with the frequency of 34 in number. It is 
important to mention here that the terms including vaccine hesitancy, severe COVID, safety, trial, 
azithromycin, vaccine development, systematic review, clinical trial, dose, meta-analysis, 
pneumonia, vaccine trial, result, survey, heparin, vaccination, and oxygen were also in the list to 
term analysis by the title of the published documents.  
Table 3 also presented the top productive sources of the published documents from 2020 to 2021. 
It presented that the name of ‘BMJ (Clinical Research Ed.)' was at the top of the list of top 
productive sources with 158 publications and 'The New England Journal of Medicine’ secured 




second position in the top productive sources list. However, the name of ‘Clinical Infectious 
Diseases' was placed at the bottom of the list with 21 publications.  
Table 3 
Published Documents by Term Analysis by Titles and Top Productive Sources 
Term Analysis by Titles 
Term f Relevance  Term f Relevance  
COVID 2632 0.7295 Dose 51 0.2935 
Vaccine 568 0.7857 Meta-Analysis 51 0.9326 
Vaccine Hesitancy 87 0.7495 Pneumonia 49 0.9789 
Severe COVID 84 1.7547 Vaccine Trial 48 0.747 
Safety 80 0.2762 Result 43 0.6585 
Trial 78 0.5625 Survey 43 0.4211 
Azithromycin 75 0.6346 Heparin 42 0.8907 
Vaccine Development 71 1.4092 Vaccination 38 0.4895 
Systematic Review 68 0.9438 Oxygen 37 0.9826 
Clinical Trial 58 0.5889 Adult 34 0.2287 
Top Productive Sources 
Source TP* % Source TP* % 
BMJ (Clinical Research 
Ed.) 
158 5.19 Journal of Medical 
Virology 
36 1.18 
The New England 
Journal of Medicine 
69 2.26 JAMA 34 1.11 
Lancet (London, 
England) 
57 1.87 Annals of The 
Rheumatic Diseases 
33 1.08 
International Journal of 
Antimicrobial Agents 
56 1.84 Human Vaccines & 
Immunotherapeutics 
31 1.01 
Annals of Internal 
Medicine 
52 1.71 Travel Medicine and 
Infectious Disease 
30 0.98 
Nature 47 1.54 Medrxiv: The Preprint 
Server for Health 
Sciences 
28 0.92 
Vaccine 47 1.54 Cureus 26 0.85 
Vaccines 44 1.44 PLOS One 24 0.78 
International Journal of 
Infectious Diseases 
43 1.41 Medical Hypotheses 22 0.72 
Trials 42 1.38 Clinical Infectious 
Diseases 
21 0.69 
TP* = Total Publications 
 
 





Figure 2. Occurrences of Term Analysis by Titles 
 
Table 4 indicated the searched topic in PubMed by top productive countries and top productive 
authors from 2020 to 2021. Bibliometric analysis indicated the name of the topic in the Coolum 
and the name of the country in the row. Similarly, the name of the authors was also shown in the 
row in the table. 










































Top Productive Countries 
USA USA USA France USA India Italy USA USA USA 
India France China USA China USA USA Australia Italy Egypt 
China India India Italy India Italy China Egypt Finland China 
Italy China Italy Brazil Italy Canada Netherlands India China France 
Canada Italy Germany Spain France Iran Brazil Brazil India Germany 
Spain Canada Iran Iran Spain Brazil Japan Germany Iran Iran 
Israel Turkey France China Japan China Sweden Italy Korea Israel 
France Brazil Canada Denmark UK Denmark Turkey Bangladesh New Zealand Italy 
Iran Netherlands Spain India Australia Egypt Australia Japan Bangladesh Panama 
Germany Spain Australia Japan Korea Argentina France France Belgium Poland 
Top Productive Authors 
Mahase E Raoult D Brainard DM Gautret P Franzini M Mahase E Li JP Sharma P Li Y Liu Y 
Iacobucci 
G 
Gautret P Cao H Raoult D 
Valdenassi 
L 
Benfield T Besser M Aaseth J Carr AC Amin K 
Ledford H Lagier JC Osinusi AO Lagier Jc Arruti E Bestle MH Cipollone F Bellomo R Hemil H Bona RD 
Dhama K Honor S Lundgren J Honor S Bertossi D Cioccari L D'ardes D Bolton D Marik PE Chang E 
Bell BP Boulware DR Wang Y Million M 
Chirumbolo 
S 
Cronhjort M Grandone E Chinni V Chalker E Chun HJ 
Dyer O Lee TC Beigel JH Hoang VT Ferrando C Gluud C Macdonald S Ischia J Liu F Defilippo N 
Hotez PJ Liu D Cao B Brouqui P Han Y Granholm A Pesavento R Jones D Peng Z Fine R 
Lee GM Mcdonald EG Chen D Colson P 
Mellado-
Artigas R 






Parola P Ricevuti G Helleberg M Thomas W Perera M Zhang J Keating C 
Bottazzi 
ME 
Nicol MR Dezure A Rolain JM Villar J Horby P Vettor R Rink L Zhu Y Lee Ai 





The overall analysis enabled us to claim that the bibliometric analysis technique allowed research 
scholars to advantage more in-depth understandings into the treatment modalities to treat COVID-
19 infection. The study is mainly based on evaluating research published in PubMed indexed 
journals of different treatment modalities to treat COVID -19 infection employing bibliometric 
analysis technique from 2020 to 2021. We concluded that a total of 3043 published documents 
were found on the subject under discussion. Vaccine and COVID-19 top were at the top of the list 
of topics of the published documents along with the United States as a top productive country. The 
name of Mahase E secured the first position in top authors, Univ. Maryland as a top organization, 
COVID-19 as a top keyword, COVID as top term analysis by title, and 'BMJ (Clinical Research 
Ed.)’ was the top of the published documents. The study recommended that other databases should 
also be used to identify treatment modalities of COVID-19 oriented topics.  
Limitations of the Study  
The present study was only based on published scholarly work in the PubMed database on different 
treatment modalities and we did not use other databases. Similarly, it focused only to evaluate 
vaccine, oxygen supplementation, dexamethasone or steroids, aspirin, heparin, remdesivir, zinc, 
vitamin c or ascorbic acid, oxygen, anti-malarial like chloroquine and hydroxychloroquine, and 
azithromycin or macrolides using bibliometric analysis. Hence, we did not use other interlinked 
variables or treatment modalities of COVID-19.  
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